A variety of team-based telehealth interventions have recently been developed and piloted in a number of practice settings. Despite the variety of intervention designs, clinical inertia (CI) continues to be problematic for therapeutic intensification and subsequent disease control.
Commentary:
Based on recent literature, pharmacists have the ability to mitigate a number of factors contributing to CI. Considering CI continues to limit overall effectiveness of team-based telehealth interventions, involving pharmacists more intentionally in these interventions would provide benefit to therapeutic intensification and therapeutic outcomes.
Get full access to this article
View all access options for this article.
References
1.
ChoudhryNK, IsaacT, LauffenburgerJC, et al.Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes: The STIC2IT cluster randomized clinical trial. JAMA Intern Med, 2018; 178:1182–1189.
2.
BandR, MortonK, StuartB, et al.Home and Online Management and Evaluation of Blood Pressure (HOME BP) digital intervention for self-management of uncontrolled, essential hypertension: A protocol for the randomised controlled HOME BP trial. BMJ Open, 2016; 6:e012684.
3.
BradburyK, MortonK, BandR, et al.Understanding how primary care practitioners perceive an online intervention for the management of hypertension. BMC Med Inform Decis Mak, 2017; 17:5–5.
4.
MohammadiR, Ayatolahi TaftiM, HoveidamaneshS, GhanavatiR, PournikO. Reflection on mobile applications for blood pressure management: A systematic review on potential effects and initiatives. Stud Health Technol Inform, 2018; 247:306–310.
5.
WoodPW, BoulangerP, PadwalRS. Home blood pressure telemonitoring: Rationale for use, required elements, and barriers to implementation in Canada. Can J Cardiol, 2017; 33:619–625.
6.
BartonAB, OkoroduduDE, BosworthHB, CrowleyMJ. Clinical inertia in a randomized trial of telemedicine-based chronic disease management: Lessons learned. Telemed J E Health, 2018; 24:742–748.
7.
CieminsEL, AroraA, CoombsNC, et al.Improving blood pressure control using smart technology. Telemed J E Health, 2018; 24:222–228.
8.
SmithSM, CarrisNW, DietrichE, et al.Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension. J Am Soc Hypertens, 2016; 10:307–317.
9.
CarterBL.Collaborative care model for hypertension. J Clin Hypertens, 2018; 20:96–97.
10.
O'ConnorPJ, Sperl-HillenJAM, JohnsonPE, RushWA, BiltzG. Advances in patient SafetyCI and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US), 2005.
11.
CarterBL, RogersM, DalyJ, ZhengS, JamesPA. The potency of team-based care interventions for hypertension: A meta-analysis. Arch Intern Med, 2009; 169:1748–1755.
12.
CarterBL, LevyB, GryzlakB, et al.Cluster-randomized trial to evaluate a centralized clinical pharmacy service in private family medicine offices. Circ Cardiovasc Qual Outcomes, 2018; 11:e004188.
